Please login to the form below

Lucid make the shortlist in all of the four categories they entered for the PMEA programme 2016

The PMEA programme rewards responsible customer-centric business practices that ensure treatments and advice provide patients with meaningful outcomes.

The awards have been specifically designed to recognise and commend excellence, best practice and innovation on a local and global scale, with programmes demonstrating a meaningful change in outcomes for patients.

2016 also marks the start of a new category - PMEA Support Agency of the Year. This category recognises excellent work from companies in support sectors who have provided their pharmaceutical clients with outstanding assistance across their businesses. The four categories Lucid entered and have been shortlisted in are:

PMEA Support Agency of the Year –
Lucid Group

Innovation – Advance Outcomes® – An Innovative Model of Medical Education to Achieve Improved, Measurable Healthcare and Patient Outcomes

Excellence in Healthcare Collaboration and Partnerships – The Ulcerative Colitis Endoscopic Index of Severity Online Tool

Excellence in Physicians / Healthcare Provider Support Programmes – PEER: Psoriasis Expert Exchange FoRum: Changing clinical behaviour on a global scale to improve standards of care in the management of psoriatic arthritis.

Dennis O’Brien (Lucid Co-founder and CEO) commented “We are delighted to have made the shortlist in all four categories we entered, in particular we are very proud to be finalists in the new category of PMEA Support Agency of the Year. We aim to improve patient outcomes in everything we do, and it is fantastic to be recognised for the support we provide.”

12th October 2016


Company Details

Lucid Group Communications Limited

0345 0536671

Contact Website

First Floor, Jubilee House
Third Avenue
Globe Park

Latest content on this profile

My Lucid journey from PMW to Head of Medical
Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced and demanding industry, but one which offers enviable flexibility, variety and intellectual challenge. Leading agency Lucid Group prides itself on the many growth and development opportunities it offers its people. In this article, Katherine Duxbury, Lucid’s Head of Medical, reflects upon her own bespoke working journey over the past 12 years and explains how creativity, collaboration and a passion for science have led to a rewarding, stimulating and self-curated career.
Lucid Group Communications Limited
Listen, learn and lift off

Lucid Group Communications Limited
Launch excellence

Lucid Group Communications Limited
Meet The Lucid Group Talent Team
Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your career to the next level with us, you can be assured that you'll have a whole group of people here cheering you on.So, if you’re feeling stuck or unfulfilled in your current role and looking for a company that will provide the personal and career development you need, please check out our open roles here: contact one of our talent acquisition managers for a chat:Ellen Field Assoc CIPDElaine DowneyJon TurnerDaniel Newbury
Lucid Group Communications Limited
Extraordinary lives: advancing change in rare diseases (Part 2)

Lucid Group Communications Limited
Extraordinary lives: advancing change in rare diseases (Part 2)
In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so important?Because 300 million people worldwide are living with a rare disease. This means that, collectively, the number of people living with a rare disease is equivalent to the population of the world's third-largest country (USA).While we have come a long way since the inception of Rare Disease Day, there's still plenty of work to do.Part 2 of this series focuses on important topics including the role of technology and the opportunities it presents for the rare disease community. The panel also hold captivating insights on how the pandemic has impacted the use of related digital technologies, the role of gene therapy, the major challenges and successes for pharma companies in supporting the rare disease community over the last 13 years, and much, much more.If you’d like to know more about the work we do in rare diseases or would like advice on any healthcare communication challenges please get in touch with Clare Reynolds on LinkedIn or by email: clare.reynolds@wearelucidgroup.comAbout Lucid GroupFounded in 2007, Lucid Group is a global multi-capability healthcare consultancy with core expertise in medical strategy, healthcare communications, creative and brand strategy, motion, digital and technology, behaviour change, metrics, and data analytics.  We partner with the pharma and biotech industry, delivering life-transforming value with connected capabilities to create pioneering solutions that change behaviour, improve clinical practice and advance health outcomes.  Transforming lives. Always.
Lucid Group Communications Limited